Taiwan Speciality Chemicals Corporation (TPEX:4772)
Taiwan · Delayed Price · Currency is TWD 247.00
+13.00 (5.56%)
Jul 27, 2026, 1:30 PM CST
TPEX:4772 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,687 | 1,050 | 873.96 | 553.52 | 532.28 | 515.67 | |
Revenue Growth | 92.40% | 20.11% | 57.89% | 3.99% | 3.22% | 23.77% |
Cost of Revenue | 775.46 | 447.19 | 406.21 | 343.31 | 278.27 | 254.5 |
Gross Profit | 911.24 | 602.53 | 467.76 | 210.21 | 254.01 | 261.17 |
Selling, General & Admin | 134.16 | 67.8 | 79.64 | 54.12 | 57.03 | 46.99 |
Research & Development | 30.67 | 24.13 | 18.44 | 18.31 | 26.19 | 18.87 |
Operating Expenses | 164.83 | 91.93 | 98.08 | 72.44 | 83.22 | 65.85 |
Operating Income | 746.41 | 510.61 | 369.67 | 137.78 | 170.79 | 195.31 |
Interest Expense | -32.39 | -20.9 | -0 | -0 | -0.13 | -2.35 |
Interest & Investment Income | 22.77 | 24.83 | 10.86 | 1.11 | 0.55 | 0.01 |
Earnings From Equity Investments | 143.79 | 143.79 | - | - | - | - |
Currency Exchange Gain (Loss) | 3.82 | -1.51 | 8.05 | -2.43 | 2.42 | -1.19 |
Other Non Operating Income (Expenses) | 2.59 | 3.78 | 2.24 | 2.79 | 6.72 | 1.33 |
EBT Excluding Unusual Items | 887 | 660.61 | 390.83 | 139.25 | 180.35 | 193.12 |
Gain (Loss) on Sale of Assets | 1.13 | 0 | -0.24 | -0.07 | -2.74 | 0.27 |
Asset Writedown | -1.54 | -1.54 | -5 | 0.02 | 9.86 | - |
Pretax Income | 886.58 | 659.07 | 385.59 | 139.2 | 187.47 | 194.45 |
Income Tax Expense | 102.58 | 39 | - | -16.45 | -20.5 | - |
Net Income | 713.47 | 620.07 | 385.59 | 155.65 | 207.97 | 194.45 |
Net Income to Common | 713.47 | 620.07 | 385.59 | 155.65 | 207.97 | 194.45 |
Net Income Growth | 75.17% | 60.81% | 147.73% | -25.16% | 6.96% | - |
Shares Outstanding (Basic) | 148 | 148 | 141 | 138 | 138 | 138 |
Shares Outstanding (Diluted) | 150 | 150 | 141 | 139 | 139 | 139 |
Shares Change | 4.69% | 6.36% | 1.71% | -0.06% | 0.07% | 0.33% |
EPS (Basic) | 4.83 | 4.20 | 2.74 | 1.13 | 1.50 | 1.41 |
EPS (Diluted) | 4.78 | 4.16 | 2.73 | 1.12 | 1.50 | 1.40 |
EPS Growth | 68.19% | 52.38% | 143.75% | -25.33% | 7.14% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 587.09 | 429.34 | 483.34 | 133.76 | 206.29 | 302.33 |
Free Cash Flow Per Share | 3.91 | 2.86 | 3.43 | 0.96 | 1.49 | 2.18 |
Dividend Per Share | 3.000 | 3.000 | 2.000 | 1.000 | 0.680 | 0.650 |
Dividend Growth | 50.00% | 50.00% | 100.00% | 47.06% | 4.61% | -84.81% |
Gross Margin | 54.02% | 57.40% | 53.52% | 37.98% | 47.72% | 50.65% |
Operating Margin | 44.25% | 48.64% | 42.30% | 24.89% | 32.09% | 37.88% |
Profit Margin | 42.30% | 59.07% | 44.12% | 28.12% | 39.07% | 37.71% |
Free Cash Flow Margin | 34.81% | 40.90% | 55.30% | 24.16% | 38.76% | 58.63% |
EBITDA | 843.91 | 584.46 | 461.23 | 256.69 | 314.39 | 327.5 |
EBITDA Margin | 50.03% | 55.68% | 52.78% | 46.37% | 59.06% | 63.51% |
D&A For EBITDA | 97.5 | 73.85 | 91.56 | 118.91 | 143.6 | 132.19 |
EBIT | 746.41 | 510.61 | 369.67 | 137.78 | 170.79 | 195.31 |
EBIT Margin | 44.25% | 48.64% | 42.30% | 24.89% | 32.09% | 37.88% |
Effective Tax Rate | 11.57% | 5.92% | - | - | - | - |